{"id":17562,"date":"2026-07-28T17:45:00","date_gmt":"2026-07-28T15:45:00","guid":{"rendered":"https:\/\/www.maunakeatech.com\/?p=17562"},"modified":"2026-07-28T17:41:49","modified_gmt":"2026-07-28T15:41:49","slug":"mauna-kea-technologies-annonce-deux-nouvelles-etudes-cliniques-revues-par-des-pairs-confirmant-la-valeur-clinique-du-cellvizio-et-de-son-association-avec-lia-dans-le-diagnostic-des-kyst","status":"publish","type":"post","link":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-deux-nouvelles-etudes-cliniques-revues-par-des-pairs-confirmant-la-valeur-clinique-du-cellvizio-et-de-son-association-avec-lia-dans-le-diagnostic-des-kyst\/","title":{"rendered":"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0"},"content":{"rendered":"\n<p class=\"has-text-align-center wp-block-paragraph\"><strong><em>Une \u00e9tude internationale inter-observateurs confirme une pr\u00e9cision diagnostique de 96% pour la distinction entre les tumeurs mucineuses et non mucineuses et une meilleure concordance entre m\u00e9decins gr\u00e2ce au Cellvizio\u00a0<\/em><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><strong><em>La combinaison IA + Cellvizio porte de 53% \u00e0 87% la pr\u00e9cision de d\u00e9tection des l\u00e9sions \u00e0 haut risque\u00a0<\/em><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Paris et Boston, le 28 juillet 2026 &#8211; 17h45 CEST &#8211; Mauna Kea Technologies (Euronext Growth : ALMKT) (la \u00ab Soci\u00e9t\u00e9 \u00bb), <\/strong>inventeur de Cellvizio<sup>\u00ae<\/sup>, la plateforme multidisciplinaire d&#8217;endomicroscopie confocale laser par minisonde et par aiguille (p\/nCLE), annonce aujourd&#8217;hui la publication de deux nouvelles \u00e9tudes dans de prestigieuses revues de gastroent\u00e9rologie. Ces travaux viennent enrichir le corpus de preuves cliniques d\u00e9montrant l\u2019int\u00e9r\u00eat de l&#8217;endomicroscopie laser confocale par aiguille (nCLE) pour le diagnostic des l\u00e9sions kystiques du pancr\u00e9as (LKP).\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Nouvelle \u00e9tude internationale inter-observateurs \u2014 Une reproductibilit\u00e9 d\u00e9montr\u00e9e entre praticiens&nbsp;<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cette \u00e9tude internationale, publi\u00e9e dans la revue <em>Gastrointestinal Endoscopy<sup>1<\/sup><\/em>, a \u00e9valu\u00e9 la coh\u00e9rence avec laquelle des m\u00e9decins ayant diff\u00e9rents niveaux d&#8217;exp\u00e9rience interpr\u00e8tent les diagnostics de kystes pancr\u00e9atiques. L&#8217;int\u00e9gration de l&#8217;imagerie Cellvizio \u00e0 l&#8217;\u00e9valuation standard a permis de porter la pr\u00e9cision du diagnostic diff\u00e9rentiel (kystes mucineux vs non mucineux) \u00e0 96%. Elle a \u00e9galement hiss\u00e9 la pr\u00e9cision d&#8217;identification des sous-types \u00e0 environ 85%, tout en am\u00e9liorant significativement la concordance entre les 15 observateurs ind\u00e9pendants. Cette reproductibilit\u00e9 inter-cliniciens constitue l&#8217;un des leviers indispensables \u00e0 une adoption \u00e0 grande \u00e9chelle.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00c9tude pionni\u00e8re en intelligence artificielle (IA) \u2014 Une pr\u00e9cision accrue pour les l\u00e9sions \u00e0 haut risque&nbsp;<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Une \u00e9tude clinique, publi\u00e9e dans <em>Techniques and Innovations in Gastrointestinal Endoscopy<sup>2<\/sup><\/em>, a \u00e9valu\u00e9 un algorithme d&#8217;intelligence artificielle guid\u00e9 par nCLE pour d\u00e9tecter la dysplasie de haut grade ou le cancer pr\u00e9coce au sein des tumeurs intracanalaires papillaires et mucineuses du pancr\u00e9as (TIPMP). Sur les sous-types de TIPMP non gastriques \u00e0 risque plus \u00e9lev\u00e9, l\u2019algorithme d\u2019IA a atteint une pr\u00e9cision de 87% contre 53% pour les m\u00e9thodes classiques, avec une sensibilit\u00e9 comparable sur l&#8217;ensemble des sous-types. Ces premiers r\u00e9sultats viennent appuyer la feuille de route de la Soci\u00e9t\u00e9, qui vise \u00e0 int\u00e9grer des outils d&#8217;aide \u00e0 la d\u00e9cision assist\u00e9s par l\u2019IA directement sur la plateforme Cellvizio.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Le Dr Somashekar (Som) Krishna, professeur de m\u00e9decine et directeur de l&#8217;endoscopie avanc\u00e9e au Wexner Medical Center de l&#8217;Universit\u00e9 d&#8217;\u00c9tat de l&#8217;Ohio<\/strong>,\u00a0a comment\u00e9 : <em>\u00ab Dans le diagnostic des kystes pancr\u00e9atiques,\u00a0le prix de l&#8217;erreur est lourd des deux c\u00f4t\u00e9s : on r\u00e9s\u00e8que \u00e0 l&#8217;exc\u00e8s des kystes b\u00e9nins, tout en passant encore \u00e0 c\u00f4t\u00e9 de certains cancers. Dans le cadre de l&#8217;\u00e9tude multicentrique CLIMB actuellement en cours qui \u00e9value l&#8217;EUS-nCLE, l&#8217;ajout de cette technique en temps r\u00e9el \u00e0 l&#8217;\u00e9valuation standard a fait passer la pr\u00e9cision diagnostique de 73 % \u00e0 85 %. De plus, elle a permis de r\u00e9duire de plus de 40 % les chirurgies inutiles pour des kystes b\u00e9nins et de diviser par pr\u00e8s de six le nombre de cancers manqu\u00e9s. Ce qui rend ces r\u00e9sultats particuli\u00e8rement probants, c&#8217;est la fa\u00e7on dont ils ont \u00e9t\u00e9 obtenus : par 15 \u00e9choendoscopistes internationaux pour qui cette technique \u00e9tait nouvelle, avec des b\u00e9n\u00e9fices qui se sont confirm\u00e9s pour l&#8217;ensemble d&#8217;entre eux. Et nous pouvons d\u00e9sormais aller plus loin : l&#8217;application de l&#8217;intelligence artificielle \u00e0 l&#8217;analyse vid\u00e9o nCLE a permis de d\u00e9tecter la dysplasie de haut grade et le cancer avec une pr\u00e9cision de 87 % dans les sous-types non gastriques de TIPMP, qui pr\u00e9sentent le risque de progression le plus \u00e9lev\u00e9. Utilis\u00e9e dans le cadre d&#8217;une approche multimodale fond\u00e9e sur la taille, la nCLE, aujourd&#8217;hui int\u00e9gr\u00e9e aux recommandations de l&#8217;ESGE, est en passe de devenir une pi\u00e8ce ma\u00eetresse pour r\u00e9soudre le casse-t\u00eate des kystes pancr\u00e9atiques. \u00bb\u00a0<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Sacha Loiseau, Ph.D., Pr\u00e9sident-Directeur G\u00e9n\u00e9ral de Mauna Kea Technologies<\/strong>, a conclu : <em>\u00ab Ce volume croissant de preuves ind\u00e9pendantes et valid\u00e9es par des pairs confirme ce que les m\u00e9decins constatent au quotidien sur le terrain : Cellvizio leur ouvre une perspective unique sur les kystes pancr\u00e9atiques, qu&#8217;aucune autre technologie ne peut offrir. Chaque intervention chirurgicale inutile \u00e9vit\u00e9e et chaque cancer d\u00e9tect\u00e9 plus t\u00f4t donnent tout son sens \u00e0 notre action. Ces r\u00e9sultats renforcent \u00e9galement notre conviction au moment o\u00f9 nous acc\u00e9l\u00e9rons l&#8217;adoption de notre solution dans les centres hospitaliers am\u00e9ricains et pr\u00e9parons l&#8217;arriv\u00e9e du diagnostic assist\u00e9 par IA sur notre plateforme. \u00bb\u00a0<\/em><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>1<\/sup> The Impact of Confocal Endomicroscopy Combined with Standard Diagnostics in Evaluating Large Pancreatic Cystic Lesions: An International Interobserver Study, https:\/\/doi.org\/10.1016\/j.gie.2026.06.067\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><sup>2<\/sup> Preoperative Prediction of Subtype and Artificial Intelligence\u2013Driven Endomicroscopy Detection of Advanced Neoplasia in Intraductal Papillary Mucinous Neoplasms. https:\/\/doi.org\/10.1016\/j.tige.2025.250956\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2026\/07\/CP_ALMKT_ResultatsPancCyst_Juillet2026_FR.pdf\">VOIR LE COMMUNIQU\u00c9 DE PRESSE<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Une \u00e9tude internationale inter-observateurs confirme une pr\u00e9cision diagnostique de 96% pour la distinction entre les tumeurs mucineuses et non mucineuses et une meilleure concordance entre m\u00e9decins gr\u00e2ce au Cellvizio\u00a0 La combinaison IA + Cellvizio porte de 53% \u00e0 87% la pr\u00e9cision de d\u00e9tection des l\u00e9sions \u00e0 haut risque\u00a0 Paris et Boston, le 28 juillet 2026 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":4222,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[29],"tags":[],"class_list":["post-17562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0 - Mauna Kea Technologies<\/title>\n<meta name=\"description\" content=\"Mauna Kea Technologies annonce aujourd&#039;hui la publication de deux nouvelles \u00e9tudes dans de prestigieuses revues de gastroent\u00e9rologie. Ces travaux viennent enrichir le corpus de preuves cliniques d\u00e9montrant l\u2019int\u00e9r\u00eat de l&#039;endomicroscopie laser confocale par aiguille (nCLE) pour le diagnostic des l\u00e9sions kystiques du pancr\u00e9as (LKP).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0 - Mauna Kea Technologies\" \/>\n<meta property=\"og:description\" content=\"Mauna Kea Technologies annonce aujourd&#039;hui la publication de deux nouvelles \u00e9tudes dans de prestigieuses revues de gastroent\u00e9rologie. Ces travaux viennent enrichir le corpus de preuves cliniques d\u00e9montrant l\u2019int\u00e9r\u00eat de l&#039;endomicroscopie laser confocale par aiguille (nCLE) pour le diagnostic des l\u00e9sions kystiques du pancr\u00e9as (LKP).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/\" \/>\n<meta property=\"og:site_name\" content=\"Mauna Kea Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/maunakeatech\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-28T15:45:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"192\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Elizabeth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:site\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elizabeth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/\"},\"author\":{\"name\":\"Elizabeth\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/46a359c122ceb464208dd447ff0dea82\"},\"headline\":\"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0\",\"datePublished\":\"2026-07-28T15:45:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/\"},\"wordCount\":860,\"image\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/\",\"name\":\"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0 - Mauna Kea Technologies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png\",\"datePublished\":\"2026-07-28T15:45:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/46a359c122ceb464208dd447ff0dea82\"},\"description\":\"Mauna Kea Technologies annonce aujourd'hui la publication de deux nouvelles \u00e9tudes dans de prestigieuses revues de gastroent\u00e9rologie. Ces travaux viennent enrichir le corpus de preuves cliniques d\u00e9montrant l\u2019int\u00e9r\u00eat de l'endomicroscopie laser confocale par aiguille (nCLE) pour le diagnostic des l\u00e9sions kystiques du pancr\u00e9as (LKP).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png\",\"contentUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png\",\"width\":330,\"height\":192,\"caption\":\"Panc Cysts\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.maunakeatech.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#website\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/\",\"name\":\"Mauna Kea Technologies\",\"description\":\"See Cells. Change Lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.maunakeatech.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/46a359c122ceb464208dd447ff0dea82\",\"name\":\"Elizabeth\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"caption\":\"Elizabeth\"},\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/author\\\/elizabeth\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0 - Mauna Kea Technologies","description":"Mauna Kea Technologies annonce aujourd'hui la publication de deux nouvelles \u00e9tudes dans de prestigieuses revues de gastroent\u00e9rologie. Ces travaux viennent enrichir le corpus de preuves cliniques d\u00e9montrant l\u2019int\u00e9r\u00eat de l'endomicroscopie laser confocale par aiguille (nCLE) pour le diagnostic des l\u00e9sions kystiques du pancr\u00e9as (LKP).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/","og_locale":"fr_FR","og_type":"article","og_title":"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0 - Mauna Kea Technologies","og_description":"Mauna Kea Technologies annonce aujourd'hui la publication de deux nouvelles \u00e9tudes dans de prestigieuses revues de gastroent\u00e9rologie. Ces travaux viennent enrichir le corpus de preuves cliniques d\u00e9montrant l\u2019int\u00e9r\u00eat de l'endomicroscopie laser confocale par aiguille (nCLE) pour le diagnostic des l\u00e9sions kystiques du pancr\u00e9as (LKP).","og_url":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/","og_site_name":"Mauna Kea Technologies","article_publisher":"https:\/\/www.facebook.com\/maunakeatech\/","article_published_time":"2026-07-28T15:45:00+00:00","og_image":[{"width":330,"height":192,"url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png","type":"image\/png"}],"author":"Elizabeth","twitter_card":"summary_large_image","twitter_creator":"@maunakeatech","twitter_site":"@maunakeatech","twitter_misc":{"\u00c9crit par":"Elizabeth","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/#article","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/"},"author":{"name":"Elizabeth","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82"},"headline":"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0","datePublished":"2026-07-28T15:45:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/"},"wordCount":860,"image":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/","url":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/","name":"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0 - Mauna Kea Technologies","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/#primaryimage"},"image":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png","datePublished":"2026-07-28T15:45:00+00:00","author":{"@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82"},"description":"Mauna Kea Technologies annonce aujourd'hui la publication de deux nouvelles \u00e9tudes dans de prestigieuses revues de gastroent\u00e9rologie. Ces travaux viennent enrichir le corpus de preuves cliniques d\u00e9montrant l\u2019int\u00e9r\u00eat de l'endomicroscopie laser confocale par aiguille (nCLE) pour le diagnostic des l\u00e9sions kystiques du pancr\u00e9as (LKP).","breadcrumb":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/#primaryimage","url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png","contentUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/9de47ed44f88f25a8bb2e1d3dafb2838948ad002.png","width":330,"height":192,"caption":"Panc Cysts"},{"@type":"BreadcrumbList","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-two-new-peer-reviewed-clinical-studies-confirming-the-clinical-value-of-cellvizio-and-its-combination-with-ai-for-the-diagnosis-of-pancreatic-cysts\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.maunakeatech.com\/"},{"@type":"ListItem","position":2,"name":"Mauna Kea Technologies annonce deux nouvelles \u00e9tudes cliniques revues par des pairs confirmant la valeur clinique du Cellvizio\u00ae et de son association avec l\u2019IA dans le diagnostic des kystes pancr\u00e9atiques\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.maunakeatech.com\/#website","url":"https:\/\/www.maunakeatech.com\/","name":"Mauna Kea Technologies","description":"See Cells. Change Lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.maunakeatech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82","name":"Elizabeth","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","caption":"Elizabeth"},"url":"https:\/\/www.maunakeatech.com\/fr\/author\/elizabeth\/"}]}},"_links":{"self":[{"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/posts\/17562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/comments?post=17562"}],"version-history":[{"count":2,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/posts\/17562\/revisions"}],"predecessor-version":[{"id":17564,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/posts\/17562\/revisions\/17564"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/media\/4222"}],"wp:attachment":[{"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/media?parent=17562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/categories?post=17562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/tags?post=17562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}